Home | Business News | Browse by Publication | P | Pharma Marketletter

Archimedes submits NasalFent MAA.

Publication: Pharma Marketletter
Publication Date: 04-MAY-09
Format: Online
Delivery: Immediate Online Access
Full Article Title: Archimedes submits NasalFent MAA.(Archimedes Pharma)(Marketing Authorization Application)(Brief article)

Article Excerpt
UK drug developer Archimedes Pharma has submitted a centralized Marketing Authorization Application to the European Medicines Evaluation Agency (EMEA) for approval of its lead product candidate, NasalFent, a fentanyl nasal spray for the rapid relief of breakthrough cancer pain.

The NasalFent development program involved over 100 investigational sites in...



More articles from Pharma Marketletter
Meiji Seika outlines plans for new fiscal year.(Meiji Seika Kaisha)(Br..., May 04, 2009
Sciele and Plethora present PSD502 PE data.(Sciele Pharma)(Plethora So..., May 04, 2009
ZymoGenetics to cut workforce by 32%.(Brief article), May 04, 2009
Solution proposed for patient medication management.(MediPACK)(Reeves-..., May 04, 2009
Dr Reddy's launches Nexret in India.(Dr Reddy's Laboratories)(Brief ar..., May 04, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.